Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de C. David Nicholson, PhD
Age : 62
Public asset : 3,429,270 USD
Linked companies : Allergan plc - Actinium Pharmaceuticals Inc
Summary 
Dr. C. D. Nicholson is Chief Research & Development Officer at Allergan Plc.

He is on the Board of Directors at Transcelerate Biopharma, Inc. and Actinium Pharmaceuticals, Inc. Dr. Nicholson was previously employed as Head-Research & Development by Bayer CropScience AG, Senior Vice President & Head-Worldwide Licensing by Merck & Co., Inc., and Executive Vice President-Research & Development by Organon Biosciences, Inc.

He also served on the board at Cactus Ventures, Inc. and Actinium Pharmaceuticals, Inc. /Old/.

He received his undergraduate degree from The University of Manchester and a doctorate degree from The University of Wales.


Current positions of C. David Nicholson, PhD 
NameTitle Since
Allergan plc
(Pharmaceuticals)
Chief Research & Development Officer 2014
Actinium Pharmaceuticals Inc
(Biotechnology & Medical Research)
Independent Director 2008
Transcelerate Biopharma, Inc. Vice Chairman 2017


Holdings of C. David Nicholson, PhD 
NameEquities%Valuation
Allergan plc (AGN)
Pharmaceuticals
19,3140.0058%3,423,020 USD
Actinium Pharmaceuticals Inc (ATNM)
Biotechnology & Medical Research
10,0000.012%6,250 USD


C. David Nicholson, PhD: Personal Network 


Most Read News 
12/08 JAMIE DIMON : JPMorgan's Dimon taking customer pricing hints from Amazon
12/11DJROBERT IGER : ConsolidationDisney Deal for Fox Would End Hollywood EraFox Would Play Supporting Role at Disney -- WSJ
12/14 MARTIN BLESSING : UBS puts wealth management in hands of ex-Commerzbank boss Blessing
12/14DJRUPERT MURDOCH : Rupert Murdoch Says Disney Deal Is a Pivot, Not a Retreat
02:06a RUPERT MURDOCH : Murdoch bets live sports and news will boost new, smaller Fox
12/12 CARL ICAHN : Xerox 'desperately' needs new leadership, Icahn says
12/12 RUPERT STADLER : Audi CEO drops plan to sell motorcycle brand Ducati
12/08 JOHN BROWN : Former BP boss Browne back with what he knows best - oil mergers
12/08 TERRY LUNDGREN : Macy's Executive Chairman Lundgren to retire in January
12/08 SAFRA CATZ : Oracle's Safra Catz among two new members named to Disney board
More news


© 2017 People and Ownership :   
Advertisement
C. David Nicholson, PhD : Connections 
Carnegie Mellon University
The New York Society of Security Analysts, Inc.
Vlaams Instituut Voor Biotechnologie - Flanders Institute
Remedy Pharmaceuticals, Inc.
Jamess Capital Group LLC
Soudal NV
reMYND NV
CFA Institute



Popular Business Leaders 
William Ackman Jean-paul Agon Liliane Bettencourt Jeff Bezos Lloyd Blankfein Vincent Bolloré Richard Branson John Bryant Warren Buffett Kenneth Chenault Gary Cohn Tim Cook Jean Coutu Jamie Dimon Ralph Dommermuth Patrick Drahi John Edwards Larry Ellison Douglas Flint Carlos Ghosn Mario Greco David Henry Heinrich Hiesinger Carl Icahn Isabelle Kocher Bruno Lafont Jack Ma Laurent Mignon Lakshmi Mittal James Murdoch Elon Musk Peter Nicholas Michael O'leary Nelson Peltz Sumner Redstone Franck Riboud Xavier Rolet Kasper Rorsted Wilbur Ross Sheryl Sandberg George Soros Ulrich Spiesshofer Johannes Teyssen François Villeroy De Galhau John Williamson Thomas Wilson Dieter Zetsche Mark Zuckerberg Isabel Dos Santos
A-Z Business Leaders